Utility of plasma tumor marker levels in management of patients with appendiceal adenocarcinoma

Authors

Abdelrahman M. Yousef, The University of Texas MD Anderson Cancer Center
Aditya More, The University of Texas MD Anderson Cancer Center
Mohammad Zeineddine, The University of Texas MD Anderson Cancer Center
Saikat Chowdhury, The University of Texas MD Anderson Cancer Center
Yue Gu, University of Texas MD Anderson Cancer Center
Julia Dansby, The University of Texas MD Anderson Cancer Center
Zahra Alavi Naini, The University of Texas MD Anderson Cancer Center
Abhineet Uppal, The University of Texas MD Anderson Cancer Center
Kanwal Raghav, The University of Texas MD Anderson Cancer Center
Michael J. Overman, The University of Texas MD Anderson Cancer Center
Keith Fournier, The University of Texas MD Anderson Cancer Center
John Paul Shen, The University of Texas MD Anderson Cancer Center

Files

Abstract

View full abstract

DOI

https://doi.org/10.52519/00095

Publication Date

2022

Department

Gastrointestinal Medical Oncology

Research Category

The Patient is the Focus

Recommended Citation

Yousef, Abdelrahman M.; More, Aditya; Zeineddine, Mohammad; Chowdhury, Saikat; Gu, Yue; Dansby, Julia; Naini, Zahra Alavi; Uppal, Abhineet; Raghav, Kanwal; Overman, Michael J.; Fournier, Keith; and Shen, John Paul, "Utility of plasma tumor marker levels in management of patients with appendiceal adenocarcinoma" (2022). Leading Edge of Cancer Research Symposium. 50.
doi:https://doi.org/10.52519/00095